Palileo-Villanueva, Lia M.
Palafox, Benjamin
Amit, Arianna Maever L.
Pepito, Veincent Christian F.
Ab-Majid, Fadhlina
Ariffin, Farnaza
Balabanova, Dina
Isa, Mohamad-Rodi
Mat-Nasir, Nafiza
My, Mazapuspavina
Renedo, Alicia
Seguin, Maureen L.
Yusoff, Khalid
Dans, Antonio L.
Mckee, Martin
Funding for this research was provided by:
Wellcome Trust/Newton Fund-MRC Humanities & Social Science Collaborative Award (200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z, 200346/Z/15/Z)
Article History
Received: 9 December 2021
Accepted: 19 September 2022
First Online: 30 September 2022
Declarations
:
: Ethical approval for this study was granted by the Observational Research Ethics Committee at the London School of Hygiene & Tropical Medicine (Ref: 12214), the Research Ethics Boards at the Universiti Putra Malaysia (JKEUPM-2017–229) and the University of the Philippines Manila (UPMREB-2017–481-01). All methods were performed in accordance with the relevant guidelines and regulations. All participants gave informed consent.
: Not applicable.
: LMP-V and ALD have been and/or are currently involved in clinical trials of antihypertensive medications that receive some funding from industry. All other author declare that they have no competing interests.